Efficacy Analysis of Ultrasound-guided 1 470 nm Intracavitary Laser Combined with Lauromacrogol Foam in the Treatment of Peripheral Arteriovenous Malformations
Objective To explore the short-term clinical efficacy ultrasound-guided 1470 nm intracavitary laser combined with lauromacrogol foam in the treatment of peripheral arteriovenous malformations.Methods 81 patients diagnosed with peripheral arteriovenous malformations admitted to the author's department from January 2019 to February 2024 were selected.According to the imaging classification of peripheral arteriovenous malformations,the patients were divided into three groups(including 14 cases in type I group,30 cases in type Ⅱ group and 37 cases in type Ⅲ group).The size of the lesion was detected before operation,and the follow-up visit was conducted one month after the combined treatment.The number of surgical treatments and the degree of lesion reduction before and after treatment was compared,and the effectiveness and safety of the treatment were analyzed.Results In this group of 81 patients,the cure rate was 29.63%,the total effective rate was 60.49% .The degree of lesion reduction and the total effective rate of treatment were higher in the type Ⅱ group than in the type Ⅰ group and the type Ⅲ group,and the number of treatment in the type Ⅲ group was significantly more than that in the type Ⅰ group and the type Ⅱ group,showing significant differences among the three groups(P<0.05).No serious complications such as dyspnea,severe allergy,organ injury and vascular embolism occurred in all patients after operation.Conclusion B ultrasound-guided 1 470 nm laser combined with lauromacrogol sclerotherapy for peripheral arteriovenous malformations has the advantages of less tissue damage,high safety and good efficacy.The best treatment scheme can be adopted according to the imaging classification of peripheral arteriovenous malformations.